As novel antitumor therapeutic agents, CRAds not only selectively replicate in and lyse tumor cells, but can also amplify the expression and efficacy of therapeutic genes.14, 15 IL‐24 can suppress cancer cell growth and induce apoptosis and is therefore commonly used in tumor gene therapy.30 This evidence concerns the gene IL24 and neoplasm.